EDGAR Filing Documents for 0001144204-15-034499

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001144204-15-034499

Filing Date

2015-05-29

Accepted

2015-05-29 16:55:04

Documents

Effectiveness Date

2015-05-29

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	v411979_defa14a.htm	DEFA14A	39892
2	GRAPHIC	line.gif	GRAPHIC	43
3	GRAPHIC	spacer.gif	GRAPHIC	43
4	GRAPHIC	logo_celsus.jpg	GRAPHIC	69846
	Complete submission text file	0001144204-15-034499.txt		137761

Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036

Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804

Celsus Therapeutics Plc. (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: DEFA14A | Act: 34 | File No.: 001-36288 | Film No.: 15900273
SIC: 2834 Pharmaceutical Preparations